Stocktoria

Lunai Bioworks Inc. LNAI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-11-18 · LEI

Lunai Bioworks Inc. statistics & valuation

Market cap$14.6M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-139.80% -4.00% -10.40% -6.90% -15.30% -156.20% -85.30% -67.00% 2016201720182019202020212022202320242025
Shares outstanding
9.5M 12.4M 36.2M 45.3M 46.5M 52.2M 53.0M 63.7M 158.5M 165.1M 2016201720182019202020212022202320242025
Net debt ($)
$79514 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-199.30% -47.40% -3.50% -10.00% -6.40% -14.10% -134.00% -68.10% -54.20% -2162.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$2.16 -$0.71 -$0.91 -$1.08 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-2162.7%-54.2%-68.1%-134.0%-14.1%-6.4%-10.0%-3.5%-47.4%-199.3%
Return on equity833.8%-67.0%-85.3%-156.2%-15.3%-6.9%-10.4%-4.0%-139.8%272.2%
Debt / equity—————————-0.16×
Current ratio0.040.070.231.4811.086.7011.2518.041.400.49

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.